Quality of Life in Hodgkin Lymphoma

The long-term cure rates for Hodgkin lymphoma (HL) patients are above 80 % for all stages. Given this impressive long-term outcome for a patient population with a median age of about 30 years at diagnosis, the quality of survivorship has become more and more important. Organ dysfunctions including hypothyroidism, hypogonadism, cardiopulmonary complications, and secondary neoplasia as well as health-related quality of life (HRQoL) are major factors contributing to the patient’s general well-being.